CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in CASI Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q1 2025
- Shares held
- 2.26M
- −489.0K (−17.8%) vs. Q1 2025
- Total value
- $2.66M
- −$3.27M (−55.1%) vs. Q1 2025
- New holders
- 3
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.66M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $920.0K |
| Q4 2023 | 18 | $1.99M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 987,259 | $1.16M | 0.09% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 787,121 | $928.8K | 0.52% | −542,262−40.8% | Reduced |
| Woodline Partners LP | 165,640 | $195.5K | 0.00% | +1,275+0.8% | Added |
| Wellington Shields Capital Management, LLC | 90,845 | $107.2K | 0.02% | −49−0.1% | Reduced |
| ADAR1 Capital Management, LLC | 44,120 | $52.1K | 0.01% | −3,300−7.0% | Reduced |
| Renaissance Technologies LLC | 39,200 | $46.3K | 0.00% | +300+0.8% | Added |
| Citadel Advisors LLC | 36,246 | $42.8K | 0.00% | +36,246 | New |
| Wellington Shields & Co., LLC | 30,091 | $35.5K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,808 | $22.2K | 0.00% | −555−2.9% | Reduced |
| Royal Bank of Canada | 19,900 | $22.0K | 0.00% | +10,200+105.2% | Added |
| Bank of America Corp | 12,061 | $14.2K | 0.00% | +11,995+18,174.2% | Added |
| Two Sigma Securities, LLC | 11,599 | $13.7K | 0.00% | +11,599 | New |
| Susquehanna International Group, LLP | 10,151 | $12.0K | 0.00% | −10,992−52.0% | Reduced |
| UBS Group AG | 954 | $1.13K | 0.00% | −2,135−69.1% | Reduced |
| Wells Fargo & Company | 505 | $596 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 365 | $431 | 0.00% | −1,125−75.5% | Reduced |
| BlackRock, Inc. | 296 | $349 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 134 | $158 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 25 | $30 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 19 | $22 | 0.00% | +19 | New |
| Northwestern Mutual Wealth Management Co | 13 | $15 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $13 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 5 | $6 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 26 | $0 | 0.00% | −88−77.2% | Reduced |
| West Paces Advisors Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −26−100.0% | Sold out |